TITLE

Synergetic interactions between rehabilitation and pharmacotherapy in COPD

AUTHOR(S)
Pepin, Véronique; Laviolette, Louis; Saey, Didier; Maltais, François
PUB. DATE
June 2006
SOURCE
Clinical & Investigative Medicine;Jun2006, Vol. 29 Issue 3, p170
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Once viewed as an irreversible condition, chronic obstructive pulmonary disease (COPD) is now considered as a preventable and treatable disease. The past ten years of research have clearly indicate that dyspnea, exercise tolerance and quality of life can be improved considerably with appropriate therapeutic interventions that include pharmacological and non-pharmacological components. It is also becoming evident that it is the concomitant use of appropriate pharmacotherapy and non-pharmacological approaches, such as exercise training and pulmonary rehabilitation, that offers the best hope for an optimal status. Purpose. The objective of this short paper is to review the rationale of combining pharmacological and non-pharmacological therapeutic approaches to optimize functional status and quality of life in patients with COPD. Principal Findings: Optimal bronchodilation is the mainstay of treatment. Leg fatigue will prevent patients with COPD from obtaining full advantage of bronchodilation. Quadriceps fatigue during cycling exercise is linked to events taking place within the muscle providing a muscular and metabolic basis to explain the observation that some patients with COPD develop contractile fatigue after exercise. Muscle fatigue can be improved with exercise training. Pharmacotherapy and exercise training offer the best hope for an optimal status in COPD Conclusion. Our goals are to stimulate interest in COPD, provide a strong case against the nihilistic approach to this disease to ultimately raise the standard of care to the benefit of the numerous patients afflicted by this condition.
ACCESSION #
21118510

 

Related Articles

  • Pulmonary Rehabilitation as Evaluated by Clinical Trials: An Overview. Riario-Sforza, Gian Galeazzo; Yacoub, Mona-Rita; Incorvaia, Cristoforo // Reviews on Recent Clinical Trials;May2010, Vol. 5 Issue 2, p76 

    During the 80' and the 90's, the role of pulmonary rehabilitation (PR) was still not clearly demonstrated. The following development of PR was mainly due to the increasing number of clinical studies providing proofs of its effectiveness, and convincing physicians, institutions, and regulatory...

  • Clinical: The management of COPD in a primary care setting. Gruffydd-Jones, Kevin // GP: General Practitioner;3/10/2006, p55 

    The article reports that the General Practice Airways Group has produced a guide to managing chronic obstructive pulmonary disease (COPD) in primary care. Sometimes GPs are confused by all the treatments available for COPD and have problems deciding which one to use. In symptomatic patients the...

  • Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Tashkin, Donald P.; Fabbri, Leonardo M. // Respiratory Research;2010, Vol. 11, p149 

    Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long-acting bronchodilators are the mainstay of therapy; as symptoms progress, guidelines recommend combining bronchodilators from...

  • Home-Based Exercise Training as Maintenance after Outpatient Pulmonary Rehabilitation. du Moulin, Marcel; Taube, Karin; Wegscheider, Karl; Behnke, Michaela; van den Bussche, Hendrik // Respiration;2009, Vol. 77 Issue 2, p139 

    Background: Pulmonary rehabilitation is successful in improving exercise capacity and quality of life in patients with chronic obstructive pulmonary disease (COPD). However, training effects diminish over time. Objectives:We evaluated the effects of simple, daily, structured, self-monitored,...

  • Effectiveness and Safety of Hypertonic Saline Inhalation Combined With Exercise Training in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Trial. Valderramas, Silvia R.; Atallah, Álvaro Nagib // Respiratory Care;Mar2009, Vol. 54 Issue 3, p327 

    BACKGROUND: Inhaled hypertonic saline is used for bronchial challenge and sputum induction in patients with chronic obstructive pulmonary disease (COPD). We studied the effects of saline aerosol inhalation before each exercise session in an 8-week pulmonary rehabilitation program. METHODS: This...

  • Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD. Aliverti, A.; Dellacà, R. L.; Mauro, A. Lo; Pedotti, A.; Rodger, K.; Stevenson, N.; Calverley, P. M. A. // Thorax;Nov2005, Vol. 60 Issue 11, p916 

    Background: Inhaled bronchodilators can increase exercise capacity in chronic obstructive pulmonary disease (COPD) by reducing dynamic hyperinflation, but treatment is not always effective. This may reflect the degree to which the abdomen allows dynamic hyperinflation to occur. Method: A double...

  • COPD symptoms in the morning: impact, evaluation and management. Roche, Nicolas; Chavannes, Niels H.; Miravitlles, Marc // Respiratory Research;Oct2013, Vol. 14 Issue 10, p1 

    Chronic obstructive pulmonary disease (COPD) symptoms in the morning, including dyspnea and sputum production, affect patients' quality of life and limit their ability to carry out even simple morning activities. It is now emerging that these symptoms are associated with increased risk of...

  • Effect of tiotropium on quality of life in COPD: a systematic review. Kaplan, Alan // Primary Care Respiratory Journal;Dec2010, Vol. 19 Issue 4, p315 

    Background: Chronic obstructive pulmonary disease (COPD) greatly affects quality of life (QoL). Although QoL is a key concern for the patient, primary endpoints in most clinical trials are objective measures of disease progression. Methods: A systematic review of double-blind randomised...

  • Antibiotic treatment and factors influencing short and ions term outcomes of acute exacerbations of chronic bronchitis. Wilson, R.; Jones, P.; Schaberg, I.; Arvis, P.; Duprat-Lomon, I.; Sagnier, P. P. // Thorax;Apr2006, Vol. 61 Issue 4, p337 

    Background: The MOSAIC study compared moxifloxacin with three standard antibiotic regimens in patients with Anthonisen type 1 acute exacerbations of chronic bronchitis (AECB). Further exploratory analyses were performed to identify prognostic factors of short and long term clinical outcomes and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics